Pharmacokinetics of domestic actoprotector drug metaprot in healthy volunteers

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 74, Issue 6, 2011, Pages 30-32

  Kibal'chich, D A ^a   Belolipetskaya, V G ^a   Blagodatskikh, S V ^a   Martsevich, S Yu ^a   Rudenko, L I ^b   Yatsuk, V R ^b  

^a N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^b ANTIVIRAL Research and Production Corporation   (Russian Federation)

Author keywords

Actoprotector; Asthenic syndrome; Ethylthiobenzimidazole; Metaprot; Pharmacokinetics

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; ETHYLTHIOBENZIMIDAZOLE; METAPROT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; BENZIMIDAZOLES; CEREBROVASCULAR DISORDERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; RUSSIA; SOMATOFORM DISORDERS; YOUNG ADULT;

EID: 80051686536     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)